Xinmai Medical Subsidiary HawkMaster™/Longyuan™ Detachable Fibered Embolization Microcoil Approved for Market Launch by NMPA

People’s Financial News, March 13 — Recently, Xinmai Medical’s subsidiary, Shanghai Hongmai Medical Technology Co., Ltd., received approval from the National Medical Products Administration (NMPA) to market HawkMaster™/Longyuan™ detachable fiber coil embolization springs. This product is suitable for embolization treatment of peripheral vascular aneurysms, arteriovenous malformations, and arteriovenous fistulas, providing more domestically produced embolization treatment options for clinical use.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin